
51 - 200 employees
Founded 2019
đ§Ź Biotechnology
đ Pharmaceuticals
đ° $90M Debt Financing - Secura Bio on 2019-03
Biotechnology ⢠Pharmaceuticals
Secura Bio, Inc. is a commercial-stage biopharmaceutical company focused on developing, commercializing, and optimizing oncology therapies. The company emphasizes commercial strategy and market access for oncology medicines, supported by clinical development capabilities (clinical trials, expanded access, investigator-sponsored studies), medical education, and patient support programs. Headquartered in Berkeley Heights, New Jersey with an office in Dublin, Ireland, Secura Bio positions itself to maximize commercial outcomes for cancer treatments such as duvelisib.
đ March 24
Improve your chances of getting an interview by checking your resume score before you apply.

51 - 200 employees
Founded 2019
đ§Ź Biotechnology
đ Pharmaceuticals
đ° $90M Debt Financing - Secura Bio on 2019-03
Biotechnology ⢠Pharmaceuticals
Secura Bio, Inc. is a commercial-stage biopharmaceutical company focused on developing, commercializing, and optimizing oncology therapies. The company emphasizes commercial strategy and market access for oncology medicines, supported by clinical development capabilities (clinical trials, expanded access, investigator-sponsored studies), medical education, and patient support programs. Headquartered in Berkeley Heights, New Jersey with an office in Dublin, Ireland, Secura Bio positions itself to maximize commercial outcomes for cancer treatments such as duvelisib.
⢠Lead the development and execution of Medical Affairs aligned HEOR and real-world evidence (RWE) data generation for hematologic oncology assets across prelaunch and postlaunch phases. ⢠Lead and identify evidence gaps relevant to clinical practice, treatment pathways, and patient outcomes in hematologic malignancies (e.g., lymphoma, leukemia, multiple myeloma). ⢠Provide strategic input into Medical Affairs plans, including integrated evidence generation and scientific communication strategies. ⢠Design and oversee observational studies, registries, chart reviews, and other RWE initiatives relevant to hematologic oncology populations. ⢠Partner with Clinical and Biostatistics teams to ensure alignment between clinical trial data and RWE generation. ⢠Oversee the development and interpretation of health economic analyses (e.g., cost effectiveness, burden of illness, healthcare resource utilization) to contextualize clinical benefit in hematologic oncology. ⢠Ensure economic and outcomes evidence is scientifically rigorous, clinically meaningful, and suitable for external scientific exchange under Medical Affairs standards. ⢠Collaborate cross functionally to ensure consistency of value messaging while maintaining Medical Affairs independence and compliance. ⢠Lead or support the development of HEOR related abstracts, posters, manuscripts, and congress submissions in hematologic oncology. ⢠Serve as a Medical Affairs HEOR subject matter expert to support MSL training, scientific platforms, and field medical needs. ⢠Support compliant scientific exchange with external experts, cooperative groups, and other stakeholders on outcomes and RWE. ⢠Work closely with Medical Directors, Clinical Development, Market Access, and Regulatory colleagues to ensure integrated and nonpromotional evidence planning. ⢠Manage external vendors and academic collaborators to ensure high quality execution of HEOR studies. ⢠Oversee timelines, deliverables, and budgets for assigned HEOR initiatives.
⢠Advanced degrees (PhD, DrPH, ScD, MD, PharmD), with experience in health economics, outcomes research, epidemiology, public health, health services research, or related fields. ⢠4-6+ years of experience in HEOR, outcomes research, or RWE within pharmaceutical, biotech, consulting, or academic environments. ⢠Candidates with advanced scientific degrees may be considered with fewer years of industry experience. ⢠First-hand experience executing site-based non-interventional studies, systematic literature reviews, claims / administrative database analysis, patient-reported outcomes and health economic modeling. ⢠Ability to translate complex data into clinically relevant insights for scientific audiences. ⢠Experience with scientific publications and congress presentations. ⢠Strong cross functional collaboration and project management skills. ⢠High standards for scientific rigor, compliance, and Medical Affairs independence. ⢠Experience in Global dossier preparation (preferably EU region). ⢠Prior experience in hematologic oncology or closely related oncology settings is strongly preferred. ⢠Demonstrated experience supporting Medical Affairs or clinical focused evidence generation. ⢠Experience supporting cross-functional internal stakeholders. ⢠Familiarity with treatment landscape of treatment and evolving standards of care in hematologic malignancies. ⢠Strong entrepreneurial spirit who can work independently and proactively. ⢠Experience working across global or regional Medical Affairs organizations.
Apply Nowđ March 24
Senior Manager/Associate Director, Biostatistics at Codera providing statistical expertise in drug development. Collaborating on clinical programs and ensuring quality control of statistical deliverables.
đ March 23
Senior Director of Strategy driving Veeva's Clinical Trial Management System adoption. Leading market growth and strategy for life sciences companies with a focus on execution and customer engagement.
đşđ¸ United States â Remote
đľ $150k - $300k / year
â° Full Time
đ Senior
đ Director
đŚ H1B Visa Sponsor
đ March 23
Senior Director of Strategy at Veeva driving Clinical Trial Management System adoption for life sciences companies with deep strategy and commercial execution.
đşđ¸ United States â Remote
đľ $150k - $300k / year
â° Full Time
đ Senior
đ Director
đŚ H1B Visa Sponsor
đ March 23
Senior Director of Strategy focusing on Veeva's CTMS market adoption and growth in life sciences. Collaborating cross-functionally to enhance product and drive customer success.
đşđ¸ United States â Remote
đľ $150k - $300k / year
â° Full Time
đ Senior
đ Director
đŚ H1B Visa Sponsor
đ March 23
Senior Director leading strategy, execution, and market acceleration for zero-emission trucks at CALSTART. Collaborating with industry and government to drive market effective technologies and policies.
đşđ¸ United States â Remote
đľ $140k - $178k / year
đ° Grant on 2022-01
â° Full Time
đ Senior
đ Director
đŚ H1B Visa Sponsor